Tuesday, 14 June 2022

Pfizer stops enrollment in Paxlovid trial in standard-risk population

Pfizer stops enrollment in Paxlovid trial in standard-risk population

Pfizer Inc said on Tuesday it would halt enrollment in a trial for its COVID-19 antiviral drug, Paxlovid, in standard-risk patients after a study revealed the treatment was not effective in reducing symptoms in that group.

U.S. FDA advisers weigh Moderna COVID vaccine heart risk for young men

Moderna's COVID-19 vaccine may have a higher risk of heart inflammation in young men than the Pfizer /BioNTech shot, according to data presented on Tuesday to U.S. Food and Drug Administration advisers weighing its use for those aged 6 to 17.

U.S. FDA advisers back authorization of Moderna COVID vaccine for ages 6-17

Advisers to the U.S. Food and Drug Administration on Tuesday recommended the authorization of Moderna Inc's COVID-19 vaccine for children and teens aged 6 to 17 years of age.

Amylyx's ALS drug would not be cost effective if priced around $170,000- ICER

Amylyx Pharmaceuticals Inc's experimental drug for neurodegenerative disease amyotrophic lateral sclerosis (ALS) would not be cost effective if priced around $170,000, an independent U.S. pricing watchdog said on Tuesday.

Moderna to invest 500 mln euros in Spain, PM Sanchez says

Moderna plans to invest around 500 million euros ($520.60 million) in a new laboratory in Spain to boost its production of vaccines, Spanish Prime Minister Pedro Sanchez said on Tuesday.

Omicron sub-variants BA.4, BA.5 account for 21% of COVID variants in U.S. - CDC

The BA.4 and BA.5 sub-variants of Omicron are estimated to make up about 8.3% and 13.3% of the coronavirus variants in the United States as of June 11, the U.S. Centers for Disease Control and Prevention (CDC) said on Tuesday.

WTO draft IP deal on COVID vaccines 'very good', UK minister says

Britain, one of the main opponents to waiving intellectual property rights for COVID-19 vaccines, praised a draft agreement and expressed hope a deal would be reached at the World Trade Organization (WTO) this week.

Air pollution cuts life expectancy by more than two years, study says

Chronic air pollution cuts average global life expectancy by more than two years per person, a study published on Tuesday showed, an impact comparable to that of smoking and far worse than HIV/AIDS or terrorism.

WHO set to decide if monkeypox represents health emergency

The World Health Organization will convene an emergency committee on Thursday next week to assess whether the monkeypox outbreak represents a public health emergency of international concern.

Canada to suspend vaccine mandates for domestic travel, civil service

Canada will suspend its requirement to be vaccinated against COVID-19 for domestic travel and to work in the civil service from June 20, the federal government said on Tuesday, after provinces lifted most health restrictions in recent months.

Related Videos

Beijing tests millions over COVID cluster at bar

Shanghai to lock down millions again

Monkeypox "will not be like COVID" - Spanish microbiologist